+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
Brain Cancer Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Brain Cancer Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011103
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain cancer diagnostics market is undergoing rapid transformation, shaped by evolving clinical demands and convergent diagnostic technologies. For senior decision-makers seeking to drive operational excellence and long-term growth, understanding the landscape of integrated solutions and regulatory trends is essential.

Market Snapshot: Brain Cancer Diagnostics Market

Between 2025 and 2026, the Brain Cancer Diagnostics Market grew from USD 5.11 billion to USD 5.78 billion and is expected to achieve a compound annual growth rate (CAGR) of 12.76%, reaching USD 11.84 billion by 2032. Market expansion is fostered by rapid technological progress in neuroimaging, molecular profiling, and digital pathology. New solutions enable healthcare providers to identify and classify tumors with increased accuracy and at earlier stages, supporting tailored clinical interventions. This ongoing innovation is strongly driven by the needs of hospitals, diagnostic laboratories, and advanced research institutions across the globe.

Scope & Segmentation

  • Technology: Imaging modalities comprise CT, MRI, and PET to provide advanced visualization. Molecular diagnostics apply next-generation sequencing (NGS) and PCR to analyze genetic material, while digital pathology offers morphological assessment and slide digitization to enhance workflow and accuracy.
  • Product Types: Capital equipment includes major diagnostic and imaging systems. Consumables cover kits, reagents, and probes essential for sample analysis. Service offerings encompass maintenance, ongoing support, and specialized staff training.
  • Indications: Diagnostics address a spectrum of tumor types such as astrocytoma, glioblastoma multiforme, meningioma, and oligodendroglioma. Each requires unique clinical and prognostic management approaches within multidisciplinary teams.
  • Distribution Channels: Offline channels focus on institutional procurement and service support, while online channels facilitate wider access to consumables and support for remote diagnostics.
  • End Users: Key users include hospitals integrating diagnostics into clinical workflows, laboratories emphasizing throughput and standardization, and research institutes advancing exploratory studies and validation methodologies.
  • Regions: The Americas, Europe Middle East & Africa, and Asia-Pacific are assessed, each reflecting specific regulatory, adoption, and commercialization patterns.

Key Takeaways for Senior Decision-Makers

  • Integrated use of imaging, molecular analysis, and digital pathology is central to optimizing diagnostic workflows and enabling personalized treatment strategies.
  • Successful implementation depends on redesigning workflows, improving sample logistics, and adopting interoperable IT systems to connect clinical and laboratory processes seamlessly.
  • With the convergence of high-resolution imaging, advanced sequencing, and artificial intelligence, decision-makers benefit from deeper insights into tumor heterogeneity, supporting precision medicine goals.
  • Service-focused differentiation, backed by validated algorithms and bundled support offerings, improves reliability and encourages regulatory compliance among client institutions.
  • Regional planning must consider diverse regulatory frameworks, reimbursement structures, and clinician adoption trends to ensure market entry and sustained growth.
  • Strong collaboration across care teams, IT specialists, and vendor partners is increasingly necessary to unlock the value of evolving brain cancer diagnostic platforms.

Tariff Impact and Supply Chain Dynamics

After 2025, changes in tariff structures influenced procurement, manufacturing, and logistics for market players. Increased duties on imported diagnostics equipment and reagents prompted many buyers to explore local sourcing and regional distribution. Manufacturers responded by establishing local production or providing comprehensive service contracts to assure reliability and continuity of supply. This climate emphasizes the importance of adaptive investment in resilient logistics and flexible procurement models for long-term institutional planning.

Methodology & Data Sources

This research integrates secondary reviews of scientific literature, regulatory filings, and public data with direct interviews involving clinicians, laboratory managers, and industry leaders. Triangulation ensures robust validation, while detailed segmentation analysis identifies technology and product adoption trends within actual clinical environments. Confidentiality and data verification protocols were strictly observed throughout each research phase.

Brain Cancer Diagnostics Market: Why This Report Matters

  • Equips executives to benchmark technology trends and optimize diagnostic workflows, supporting continuous improvement in precision and operational performance.
  • Delivers actionable analysis of shifting commercial approaches, regulatory developments, and regional factors shaping adoption patterns in brain cancer diagnostics.
  • Supports resilient strategic planning by highlighting adaptable supply chain strategies and collaborative approaches that drive ongoing innovation and institutional growth.

Conclusion

As diagnostic pathways for brain cancer become more integrated and technology-driven, leaders who prioritize innovation, skilled workforce training, and agile supply chain management will be well-positioned to maximize clinical outcomes and foster sustainable impact in the marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain Cancer Diagnostics Market, by Technology
8.1. Genetic Testing
8.2. Imaging
8.2.1. CT Scan
8.2.2. MRI
8.2.3. PET
8.3. Molecular Diagnostics
8.3.1. NGS
8.3.2. PCR
8.4. Pathology
8.4.1. Biopsy Analysis
8.4.2. Histopathology
9. Brain Cancer Diagnostics Market, by Product
9.1. Consumables & Reagents
9.1.1. Kits
9.1.2. Probes & Reagents
9.2. Equipment
9.2.1. Diagnostic Systems
9.2.2. Imaging Systems
9.2.3. Lab Instruments
9.3. Services
9.3.1. Maintenance
9.3.2. Training & Support
10. Brain Cancer Diagnostics Market, by Indication
10.1. Astrocytoma
10.2. Glioblastoma Multiforme
10.3. Meningioma
10.4. Oligodendroglioma
11. Brain Cancer Diagnostics Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Brain Cancer Diagnostics Market, by End User
12.1. Diagnostic Laboratories
12.2. Hospitals
12.3. Research Institutes
13. Brain Cancer Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Brain Cancer Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Brain Cancer Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Brain Cancer Diagnostics Market
17. China Brain Cancer Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. Associated Regional and University Pathologists, Inc.
18.8. Becton, Dickinson and Company
18.9. Bristol Myers Squibb Co.
18.10. Canon Medical Systems Corporation
18.11. F. Hoffmann-La Roche Ltd.
18.12. Fujifilm Holdings Corporation
18.13. General Electric Company
18.14. Grail, LLC
18.15. Henry Ford Health
18.16. Hitachi, Ltd.
18.17. Hologic, Inc.
18.18. Illumina, Inc.
18.19. Invitae Corporation
18.20. Koninklijke Philips N.V.
18.21. Laboratory Corporation of America Holdings
18.22. NantOmics
18.23. NeoGenomics Laboratories, Inc.
18.24. Novocure GmbH
18.25. Oncologica Limited
18.26. QIAGEN N.V.
18.27. Quibim, S.L.
18.28. Siemens Healthineers AG
18.29. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PROBES & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PROBES & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PROBES & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY LAB INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY LAB INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY LAB INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MENINGIOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MENINGIOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OLIGODENDROGLIOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OLIGODENDROGLIOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 155. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 158. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 160. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 161. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. EUROPE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 179. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 180. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 181. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 182. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 184. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 185. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 186. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 204. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 206. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 207. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 208. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 209. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 210. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 211. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212. ASEAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 215. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 216. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 217. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 218. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 219. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 220. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 221. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 222. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 223. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. GCC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 240. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 242. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 243. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 244. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 245. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 246. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 247. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. BRICS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 252. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 253. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 254. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 255. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 256. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 257. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 258. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 259. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. G7 BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 263. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 264. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 265. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 266. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 267. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 268. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 269. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 270. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 271. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. NATO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 288. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 289. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 290. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 291. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 292. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 293. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 294. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 295. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 296. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 297. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Brain Cancer Diagnostics market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Associated Regional and University Pathologists, Inc.
  • Becton, Dickinson and Company
  • Bristol Myers Squibb Co.
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Grail, LLC
  • Henry Ford Health
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • NantOmics
  • NeoGenomics Laboratories, Inc.
  • Novocure GmbH
  • Oncologica Limited
  • QIAGEN N.V.
  • Quibim, S.L.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.84 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Brain Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents & Consumables, Software & AI Solutions), Technique (Imaging, Molecular Diagnostics), Cancer Type, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Brain Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents & Consumables, Software & AI Solutions), Technique (Imaging, Molecular Diagnostics), Cancer Type, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities - Product Image

Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities

  • Report
  • 278 Pages
  • Global
From
Breast Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Head & Neck Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Brain Cancer Diagnostics Market

In the realm of medical diagnostics, the Brain Cancer Diagnostics market is a specialized segment focused on the identification and characterization of brain tumors. Diagnostics for brain cancer are critical for formulating effective treatment plans, as the nature and progression of brain tumors can vary greatly. The market includes various diagnostic modalities such as imaging techniques, biopsy procedures, and molecular and genetic tests. Imaging tests such as MRI and CT scans are often the first step in diagnosing brain cancer, providing detailed images of the brain to detect abnormalities. Biopsies, wherein tissue samples are extracted from the suspected cancerous region, provide definitive diagnosis. Advanced methods to analyze tissue samples include histopathological examination, immunohistochemistry, and molecular testing, which can give insight into specific genetic mutations and markers that may influence treatment strategies. As medical technology advances, the introduction of new diagnostic tools and methods continues to evolve the field. With the integration of artificial intelligence and machine learning, there is a growing potential for improved diagnosis accuracy and personalized treatment approaches. Some notable companies operating in the Brain Cancer Diagnostics market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Hitachi Medical Corporation, and Agilent Technologies. These organizations are involved in the production of imaging equipment, development of molecular diagnostics, and provision of services essential for the accurate diagnosis and management of brain cancers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.